MicrobiologybioRxivPreprint
Modeling Risk Group 4 virus infection and antiviral treatment in microfluidic lung organ-on-chips in maximum containment laboratories
Sushma M. Bhosle, Julie P. Tran, Shuǐqìng Yú…·Gabriella Worwa
The paper demonstrates the use of microfluidic lung organ-on-chips to model NiV infection and evaluate antiviral treatments in a biosafety level 4 lab.
DOI 10.64898/2026.08.24.745299